Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Augmentin 125/31 oral suspension (GlaxoSmithKline UK Ltd) |
| BNF code | 0501013K0BBAPAH |
| Virtual Medicinal Product | Co-amoxiclav 125mg/31mg/5ml oral suspension |
| Name | Augmentin 125/31 oral suspension |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Augmentin 125/31 oral suspension (GlaxoSmithKline UK Ltd) 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.0.0_20251103000001, imported on 4th November 2025 at 04:00:10.